JCN Newswire
TOKYO, Dec 11, 2024 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has received approval for “URECE®” (brand name in China: “优乐思®”, generic name: dotinurad) from the National Medical Products Administration in China as a treatment for gout patients with hyperuricemia.This approval is based on the results of a multicenter…
Read More
Eisai’s “URECE(R)” (Dotinurad) Approved in China for Gout Patients with Hyperuricemia
Michele Howe
02:20
TOKYO, Dec 11, 2024 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has received approval for “URECE®” (brand name in China: “优乐思®”, generic name: dotinurad) from the National Medical Products Administration in China as a treatment for gout patients with hyperuricemia.This approval is based on the results of a multicenter…
